Search results

Dr Linda Croton, a Research Fellow at Monash University, has been awarded the 2020 ANSTO Australian Synchrotron Stephen Wilkins Thesis medal for her outstanding work using synchrotron-based X-ray for brain imaging.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

Analysing the microstructure of paracetamol using synchrotron infrared optical technique provides insights.

In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

New facility will greatly enhance Australia’s capability in stress engineering for industry

ANSTO is coordinating and facilitating the calling of pre-concept papers for the next cycle of technical cooperative project proposals under the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA) | IAEA

ANSTO has provided supporting experimental evidence of a highly unusual quantum state, a quantum spin liquid (QSL), in a two-dimensional material.

The Australian Centre for Neutron Scattering (ACNS) is a major research facility for neutron science that comprises a suite of neutron instruments with a range of techniques for scientific investigations in physics, chemistry, materials science, medicine and environmental science among other fields.

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

Research represents significant step towards developing vaccine

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

Outstanding individuals and teams have been recognised for their outstanding work, innovation, excellence in the 2025 ANSTO Awards. 

Pioneering work on materials for energy production, such as lithium ion batteries, has made ANSTO a centre of specialist capabilities and expertise.

ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.